Eric Coldwell

Stock Analyst at Baird

(5.00)
# 8
Out of 4,853 analysts
192
Total ratings
56.48%
Success rate
124.07%
Average return

Stocks Rated by Eric Coldwell

Premier
May 15, 2025
Maintains: Neutral
Price Target: $19$22
Current: $23.12
Upside: -4.84%
Charles River Laboratories International
May 8, 2025
Maintains: Neutral
Price Target: $118$140
Current: $145.13
Upside: -3.53%
IQVIA Holdings
May 7, 2025
Maintains: Neutral
Price Target: $195$161
Current: $151.71
Upside: +6.12%
ICON Public Limited Company
May 2, 2025
Maintains: Neutral
Price Target: $192$160
Current: $138.51
Upside: +15.52%
Cardinal Health
May 2, 2025
Maintains: Outperform
Price Target: $156$170
Current: $154.07
Upside: +10.34%
Labcorp Holdings
Apr 30, 2025
Maintains: Outperform
Price Target: $253$267
Current: $252.08
Upside: +5.92%
Medpace Holdings
Apr 23, 2025
Maintains: Neutral
Price Target: $340$313
Current: $299.94
Upside: +4.35%
Quest Diagnostics
Apr 23, 2025
Maintains: Outperform
Price Target: $191$194
Current: $174.63
Upside: +11.09%
Owens & Minor
Mar 3, 2025
Maintains: Neutral
Price Target: $10$11
Current: $7.83
Upside: +40.49%
AdaptHealth
Feb 27, 2025
Maintains: Outperform
Price Target: $14$16
Current: $9.05
Upside: +76.80%
Downgrades: Neutral
Price Target: $28$25
Current: $5.14
Upside: +386.38%
Upgrades: Outperform
Price Target: $531$688
Current: $707.52
Upside: -2.76%
Downgrades: Neutral
Price Target: $51
Current: $11.26
Upside: +353.13%
Maintains: Neutral
Price Target: $35$45
Current: $56.52
Upside: -20.38%
Maintains: Neutral
Price Target: $62$66
Current: $63.39
Upside: +4.12%
Maintains: Outperform
Price Target: $67$46
Current: $1.51
Upside: +2,946.36%